Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma -a systematic review and meta-analysis.

[1]  T. Seufferlein,et al.  Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication , 2021, Cancers.

[2]  P. Hegyi,et al.  Accelerating the translational medicine cycle: the Academia Europaea pilot , 2021, Nature Medicine.

[3]  S. Dima,et al.  Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma , 2021, International journal of molecular sciences.

[4]  T. Ohtsuka,et al.  Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples , 2020, Diagnostics.

[5]  In‐San Kim,et al.  Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy , 2020, Advanced materials.

[6]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[7]  Xiangxuan Zhao,et al.  The potential roles of exosomes in pancreatic cancer initiation and metastasis , 2020, Molecular Cancer.

[8]  F. Wang,et al.  The involvement of exosomes in the diagnosis and treatment of pancreatic cancer , 2020, Molecular Cancer.

[9]  Chen Huang,et al.  Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer , 2020, Molecular therapy. Nucleic acids.

[10]  A. Murrone,et al.  P-117 Prognostic role of plasmatic exosomal and tissue caveolin-1 in metastatic pancreatic cancer patients , 2020 .

[11]  A. Pickles,et al.  Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits , 2020, Journal of clinical medicine.

[12]  T. Kim,et al.  Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review , 2020, Insights into Imaging.

[13]  Swarnali Acharyya,et al.  Understanding cachexia in the context of metastatic progression , 2020, Nature Reviews Cancer.

[14]  M. Reese,et al.  Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma , 2020, Cancers.

[15]  Xuelei Ma,et al.  Diagnostic value of various liquid biopsy methods for pancreatic cancer , 2020, Medicine.

[16]  Christopher J. Lyon,et al.  Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular Vesicles , 2019, Front. Genet..

[17]  S. Dabernat,et al.  CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma , 2019, Translational oncology.

[18]  T. Ohtsuka,et al.  Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma , 2019, Annals of Surgical Oncology.

[19]  C. Pilarsky,et al.  c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer , 2019, International journal of molecular sciences.

[20]  L. Zhong,et al.  Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer , 2019, Metabolomics.

[21]  G. Santoni,et al.  Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy , 2019, PloS one.

[22]  F. Miura,et al.  Exosome‐encapsulated microRNA‐4525, microRNA‐451a and microRNA‐21 in portal vein blood is a high‐sensitive liquid biomarker for the selection of high‐risk pancreatic ductal adenocarcinoma patients , 2019, Journal of hepato-biliary-pancreatic sciences.

[23]  A. Maitra,et al.  Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. , 2019, Gastroenterology.

[24]  V. Heinemann,et al.  Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[26]  Hui Liu,et al.  Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer , 2018, Cellular Physiology and Biochemistry.

[27]  Jin Zhu,et al.  Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. , 2018, Cancer letters.

[28]  Chen Huang,et al.  Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. , 2018, Cancer research.

[29]  Krisztina V. Vukman,et al.  Detection and proteomic characterization of extracellular vesicles in human pancreatic juice. , 2018, Biochemical and biophysical research communications.

[30]  Hui Liu,et al.  Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma , 2018, Oncogene.

[31]  J. Joo,et al.  Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma. , 2018, Clinical chemistry.

[32]  F. Miura,et al.  Usefulness of exosome‐encapsulated microRNA‐451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma , 2018, Journal of hepato-biliary-pancreatic sciences.

[33]  T. Okumura,et al.  An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker , 2018, BMC Cancer.

[34]  F. Meric-Bernstam,et al.  Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers , 2017, Clinical Cancer Research.

[35]  E. Nakakura,et al.  Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[36]  P. Mangu,et al.  Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. , 2017, Journal of oncology practice.

[37]  S. Hanash,et al.  High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[39]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[40]  C. Bombardier,et al.  Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.

[41]  M. McHugh.  Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[42]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[43]  Y. Jeng,et al.  Pancreatic cancer-derived small extracellular vesical Ezrin regulates macrophage polarization and promotes metastasis. , 2020, American journal of cancer research.